AI assistant
BIOXYNE LIMITED — Director's Dealing 2017
Oct 31, 2017
64594_rns_2017-10-31_d376144c-f751-4655-99f7-69e87fb89261.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity Bioxyne Limited ABN 97 084 464 193
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Mr Patrick Ford |
|---|---|
| Date of last notice | 30 May 2017 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. | 1. Diskdew Pty Ltd2. P Ford Superannuation Pty Ltd astrustee for the Patrick Ford SuperFund A/C |
| Date of change | 31 October 2017 |
| No. of securities held prior to change | 1.8,300,000 fully paid ordinary sharesand 2,075,000 unlisted optionexercise price $0.01 with expiry 15December 20172.10,000,000 fully paid ordinaryshares and 2,500,000 unlistedoptions exercisable at $0.01 pershare expiry 15 December 20171,250,000 options exercisable at 2.34 centsper sharewith expiry24November 2019 |
| Class | Ordinary shares |
- See chapter 19 for defined terms.
Appendix 3Y Page 1
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
| Number acquired | 500,000 ordinary shares |
|---|---|
| Number disposed | Nil |
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation | $0.036 per share |
| No. of securities held after change | 1.8,800,000 fully paid ordinary sharesand 2,075,000 unlisted optionexercise price $0.01 with expiry 15December 20172.10,000,000 fully paid ordinaryshares and 2,500,000 unlistedoptions exercisable at $0.01 pershare expiry 15 December 20171,250,000 options exercisable at 2.34 centsper share with expiry 24 November 2019 |
| Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back | On market purchase |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | |
| Name of registered holder(if issued securities) | |
| Date of change | |
| No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed | |
| Interest acquired | |
| Interest disposed |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change
Part 3 –[+] Closed period
| Were the interests in the securities or contracts detailed | No |
|---|---|
| above traded during a+closed period where prior | |
| written clearance was required? | |
| If so, was prior written clearance provided to allow the | N/A |
| trade to proceed during this period? | |
| If prior written clearance was provided, on what date | N/A |
| was this provided? |
- See chapter 19 for defined terms.
Appendix 3Y Page 3
11/3/2002